publication venue for
- FDA Advisory Committee Review of Supplemental Indications and Reasons for Non-Approval, 2008-2022.. 1-8. 2025
- "Unjustified Partiality or Impartial Bias? Reckoning with Age and Disability Discrimination in Cancer Clinical Trials".. 52:731-733. 2024
- A Public Option for Clinical Trials? Lessons from Convalescent Plasma.. 52:98-100. 2024
- Targeting Health-Related Social Risks in the Clinical Setting: New Policy Momentum and Practice Considerations.. 51:777-785. 2024
- "A Raw Blessing" - Caregivers' Experiences Providing Care to Persons Living with Dementia in the COVID-19 Pandemic.. 51:626-640. 2023
- Ethics and Medical Aid in Dying: Physicians' Perspectives on Disclosure, Presence, and Eligibility.. 51:641-650. 2023
- Creating the Truth with Persons Living with Advanced Dementia.. 49:266-268. 2021
- Engaging Social Justice Methods to Create Palliative Care Programs That Reflect the Cultural Values of African American Patients with Serious Illness and Their Families: A Path Towards Health Equity.. 49:222-230. 2021
- From Exceptionalism to Essentialism in Dentistry.. 49:89-91. 2021
- Transparency of Regulatory Data across the European Medicines Agency, Health Canada, and US Food and Drug Administration.. 49:456-485. 2021
- The Supreme Court's Latest Ruling on Drug Liability and its Implications for Future Failure-to-Warn Litigation.. 47:783-787. 2019
- Biomarkers as Surrogate Endpoints: Ongoing Opportunities for Validation.. 47:393-395. 2019
- Conflicts over control and use of medical records at the New York hospital before the standardization movement.. 39:640-8. 2011
- Is the tobacco settlement constitutional?. 34:748-52. 2006
- The use of medical records in research: what do patients want?. 31:429-33. 2003